BNB Treasury Company Applied DNA Completes PIPE Financing, Acquires an Additional 4,908 BNB

On October 22nd, Applied DNA Sciences, Inc. (NASDAQ: BNBX), a biotechnology company concentrating on advancing a revenue-generating BNB digital asset treasury strategy and commercializing nucleic acid production solutions, announced today the successful accomplishment of the previously declared Public Investment in Private Equity (PIPE) financing, which was led by institutional DeFi and TradFi investors. This PIPE financing round brought approximately $27 million in total receipts to the company (after deducting underwriting and related expenses), and there is the potential for an additional $31 million in total receipts through the exercise of warrants. The total proceeds from this PIPE round consist of: $15.3 million in cash and stablecoins; and $11.71 million in OBNB Trust Units (units of the OBNB trust). The company received 0.126 OBNB Trust Units for each prefunded warrant and common warrant, totaling 435,638 trust units, representing an indirect ownership stake in 10,647 BNB tokens. In addition, the company also announced today that it has acquired an additional 4,908 BNB tokens, with a total value of approximately $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.